About Anaveon
Anaveon develops engineered antibodies and biologics that target regulatory nodes of the immune system. The company's products are designed to selectively eliminate or reprogram pathogenic immune cells in autoimmune diseases. Anaveon also develops IL-2 complexes that promote effector T cell functions for efficacy against cancer.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Basel, Switzerland
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
anaveon.com
Domain Registered Date
Nov 15, 2017
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $120,000,000 · Series-B+
startupintros.com
- Milestone
X account created (@AgAnaveon)
30 followers
- Capital Raise
Raised $35,000,000 · Series-A
startupintros.com
- Milestone
Website domain registered
anaveon.com
Investors & Backers
Cowen Healthcare Investments
Forbion Capital Partners
Novartis Venture Fund
Pfizer Venture Investments
Pontifax
Syncona Partners LLP
Funding History
Series-B+
· Dec 16, 2021
$120,000,000 startupintros.com
Series-A
· Feb 1, 2019
$35,000,000 startupintros.com
Founders & Leadership
Andreas Katopodis
Founder
Work email & phone locked
Unlock →
Christoph Huber
Chief Scientific Officer
Work email & phone locked
Unlock →
Eric Zanelli
Chief Scientific Officer
Work email & phone locked
Unlock →
Laetitia Pouzol
Chief Scientific Officer
Work email & phone locked
Unlock →
Onur Boyman
Founder
Work email & phone locked
Unlock →
Thaminda Ramanayake
Chief Executive Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026